Skip to main content
SpringerLink
Log in

Fecal DNA-based detection of colorectal neoplasia

  • Published:
Current Colorectal Cancer Reports

Abstract

Human DNA fragments, as well as whole colonocytes, can be found in stool and interrogated for mutations associated with carcinogenesis. Multiplexed panels of point mutations in fecal DNA improved the sensitivity of cancer detection (51.6%; 95% CI, 34.8%–68%) compared with fecal occult blood testing (12.9%; 95% CI, 5.1–28.9). However, the multiplex panels are not more sensitive than fecal occult blood testing in detecting advanced adenomas. Markers of epigenetic events, such as DNA methylation of gene promoters in genes not previously known to be associated with carcinogenesis or colorectal cancer, have recently been shown to be potential markers for early detection. Future approaches to improve sensitivity of fecal DNA detection of colorectal adenocarcinoma may require the inclusion of epigenetic biomarkers, the use of colonocytes isolated from feces, or both.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American Cancer Society: Cancer Facts & Figures 2007. Atlanta: American Cancer Society; 2007.

    Google Scholar 

  2. Coughlin SS, Thompson TD, Seeff L, et al.: Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Cancer 2002, 95:2211–2222.

    Article  PubMed  Google Scholar 

  3. Sirovich BE, Schwartz LM, Woloshin S: Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 2003, 289:1414–1420.

    Article  PubMed  Google Scholar 

  4. Guide to Clinical Preventive Services, 2006: Recommendations of the U.S. Preventive Services Task Force. AHRQ Publication No. 06-0588. Rockville, MD: Agency for Healthcare Research and Quality; 2006.

  5. Smith RA, von Eschenbach AC, Wender R, et al.: American Cancer Society Guidelines on Screening and Surveillance for the Early Detection of Adenomatous Polyps and Colorectal Cancer. Atlanta: American Cancer Society; 2001.

    Google Scholar 

  6. Vijan S, Inadomi J, Hayward RA, et al.: Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 2004, 20:507–515.

    Article  PubMed  CAS  Google Scholar 

  7. Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003, 124:544–560.

    Article  PubMed  Google Scholar 

  8. Lieberman DA, Weiss DG, Bond JH, et al.: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000, 343:162–168.

    Article  PubMed  CAS  Google Scholar 

  9. Davies RJ, Miller R, Coleman N: Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005, 5:199–209.

    Article  PubMed  CAS  Google Scholar 

  10. Wu GH, Wang YM, Yen AM, et al.: Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer 2006, 6:136.

    Article  PubMed  Google Scholar 

  11. Rex DK, Rahmani EY, Haseman JH, et al.: Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997, 112:17–23.

    Article  PubMed  CAS  Google Scholar 

  12. Osborn NK, Ahlquist DA: Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005, 128:192–206.

    Article  PubMed  CAS  Google Scholar 

  13. Berger BM, Schroy PC 3rd, Rosenberg JL, et al.: Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin Colorectal Cancer 2006, 5,:338–343.

    PubMed  Google Scholar 

  14. Eastwood GL: Gastrointestinal epithelial renewal. Gastroenterology 1977, 72:962–975.

    PubMed  CAS  Google Scholar 

  15. Barkla DH, Gibson PR: The fate of epithelial cells in the human large intestine. Pathology 1999, 31:230–238.

    Article  PubMed  CAS  Google Scholar 

  16. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91–100.

    Article  PubMed  Google Scholar 

  17. Sidransky D, Tokino T, Hamilton SR, et al.: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992, 256:102–105.

    Article  PubMed  CAS  Google Scholar 

  18. Matsushita H, Matsumura Y, Moriya Y, et al.: A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology 2005, 129:1918–1927.

    Article  PubMed  Google Scholar 

  19. Davidson LA, Lupton JR, Miskovsky E, et al.: Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study. Biomarkers 2003, 8:51–61.

    Article  PubMed  CAS  Google Scholar 

  20. Eguchi S, Kohara N, Komuta K, Kanematsu T: Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 1996, 77:1707–1710.

    PubMed  CAS  Google Scholar 

  21. Traverso G, Shuber A, Levin B, et al.: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002, 346:311–320.

    Article  PubMed  CAS  Google Scholar 

  22. Vogelstein B, Kinzler KW: Digital PCR. Proc Natl Acad Sci U S A 1999, 96:9236–9241.

    Article  PubMed  CAS  Google Scholar 

  23. Dong SM, Traverso G, Johnson C, et al.: Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001, 93:858–865.

    Article  PubMed  CAS  Google Scholar 

  24. Ahlquist DA, Skoletsky JE, Boynton KA, et al.: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000, 119:1219–1227.

    Article  PubMed  CAS  Google Scholar 

  25. Tagore KS, Lawson MJ, Yucaitis JA, et al.: Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer 2003, 3:47–53.

    Article  PubMed  CAS  Google Scholar 

  26. Syngal S, Stoffel E, Chung D, et al.: Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer 2006, 106:277–283.

    Article  PubMed  CAS  Google Scholar 

  27. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004. 351:2704–2714.

    Article  PubMed  CAS  Google Scholar 

  28. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759–767.

    Article  PubMed  CAS  Google Scholar 

  29. Song K, Fendrick AM, Ladabaum U: Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 2004, 126:1270–1279.

    Article  PubMed  Google Scholar 

  30. Brenner DE, Rennert G: Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst 2005, 97:1107–1109.

    Article  PubMed  Google Scholar 

  31. Petko Z, Ghiassi M, Shuber A, et al.: Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005. 11:1203–1209.

    PubMed  CAS  Google Scholar 

  32. Chen WD, Han ZJ, Skoletsky J, et al.: Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005, 97:1124–1132.

    Article  PubMed  CAS  Google Scholar 

  33. Samuels Y, Wang Z, Bardelli A, et al.: High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304:554.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gastroenterology, University of Michigan Health System, 3912 Taubman Center 0362, Ann Arbor, MI, 48109-0362, USA

    D. Kim Turgeon

Authors
  1. D. Kim Turgeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dean E. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Kim Turgeon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turgeon, D.K., Brenner, D.E. Fecal DNA-based detection of colorectal neoplasia. Curr colorectal cancer rep 3, 171–177 (2007). https://doi.org/10.1007/s11888-007-0027-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-007-0027-1

Keywords

Search

Navigation